Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.

Abouraya M, Sacco JC, Kahl BS, Trepanier LA.

Br J Clin Pharmacol. 2011 Apr;71(4):566-74. doi: 10.1111/j.1365-2125.2010.03889.x.

2.

Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.

Bhusari S, Abouraya M, Padilla ML, Pinkerton ME, Drescher NJ, Sacco JC, Trepanier LA.

Arch Toxicol. 2010 Aug;84(8):597-607. doi: 10.1007/s00204-010-0530-z. Epub 2010 Mar 11.

3.

Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection.

Wong YY, Rakasz EG, Gasper DJ, Friedrich TC, Trepanier LA.

Toxicology. 2016 Aug 10;368-369:10-18. doi: 10.1016/j.tox.2016.08.010. Epub 2016 Aug 23.

PMID:
27565715
4.

Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction.

Pyle RC, Butterfield JH, Volcheck GW, Podjasek JC, Rank MA, Li JT, Harish A, Poe KL, Park MA.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):52-8. doi: 10.1016/j.jaip.2013.11.002.

PMID:
24565769
5.

Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study.

Lavergne SN, Volkman EM, Maki JE, Yoder AR, Trepanier LA.

Toxicology. 2005 Mar 1;208(1):63-72.

PMID:
15664433
6.

Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.

Sacco JC, Trepanier LA.

Pharmacogenet Genomics. 2010 Jan;20(1):26-37. doi: 10.1097/FPC.0b013e3283343296.

7.

Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.

Lavergne SN, Kurian JR, Bajad SU, Maki JE, Yoder AR, Guzinski MV, Graziano FM, Trepanier LA.

Toxicology. 2006 May 1;222(1-2):25-36. Epub 2006 Feb 13.

PMID:
16473451
10.
11.

Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazole-nitroso in HIV infection.

Trepanier LA, Yoder AR, Bajad S, Beckwith MD, Bellehumeur JL, Graziano FM.

J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1041-50.

PMID:
15247557
12.

Cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.

Buijs BS, van den Berk GE, Boateng CP, Hoepelman AI, van Maarseveen EM, Arends JE.

AIDS. 2015 Apr 24;29(7):785-91. doi: 10.1097/QAD.0000000000000612.

PMID:
25985401
13.

Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazole.

Feola DJ, Garvy BA, Rapp RP, Thornton AC.

Pharmacotherapy. 2007 Jul;27(7):937-47.

PMID:
17594199
14.

Mild rhabdomyolysis after high-dose trimethoprim-sulfamethoxazole in a patient with HIV infection.

Anders HJ, Bogner JR, Goebel FD.

Eur J Med Res. 1997 May 28;2(5):198-200.

PMID:
9153343
15.

Trimethoprim-sulfamethoxazole induced aseptic meningitis in a renal transplant patient.

Muller MP, Richardson DC, Walmsley SL.

Clin Nephrol. 2001 Jan;55(1):80-4. Review.

PMID:
11200873
16.

Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS.

Nielsen TL, Jensen BN, Nelsing S, Mathiesen LR, Skinhøj P, Nielsen JO.

Scand J Infect Dis. 1995;27(3):217-20.

PMID:
8539544
17.
18.

Stimulation of human T cells with sulfonamides and sulfonamide metabolites.

Castrejon JL, Berry N, El-Ghaiesh S, Gerber B, Pichler WJ, Park BK, Naisbitt DJ.

J Allergy Clin Immunol. 2010 Feb;125(2):411-418.e4. doi: 10.1016/j.jaci.2009.10.031.

PMID:
20159253
19.

Trimethoprim-sulfamethoxazole-induced Steven Johnson syndrome in an HIV-infected patient.

Taqi SA, Zaki SA, Nilofer AR, Sami LB.

Indian J Pharmacol. 2012 Jul-Aug;44(4):533-5. doi: 10.4103/0253-7613.99346.

20.

Bioequivalence of two commercial preparations of trimethoprim/sulfamethoxazole: a randomized, single-dose, single-blind, crossover trial.

Alonso Campero R, Bernardo Escudero R, Del Cisne Valle Alvarez D, González de la Parra M, Namur Montalvo S, Burke Fraga V, Silva Hernandez R, De Lago Acosta A.

Clin Ther. 2007 Feb;29(2):326-33.

PMID:
17472824

Supplemental Content

Support Center